| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000021370 |
| Receipt No. | R000024647 |
| Scientific Title | Prospective observational study on safety of intraperitoneal access port system in intraperitoneal chemotherapy for gastric cancer |
| Date of disclosure of the study information | 2016/03/07 |
| Last modified on | 2021/03/12 (Ver. 4) |
| Basic information | ||
| Public title | Prospective observational study on safety of intraperitoneal access port system in intraperitoneal chemotherapy for gastric cancer | |
| Acronym | Obeseravational study on safety of intraperitoneal access port system | |
| Scientific Title | Prospective observational study on safety of intraperitoneal access port system in intraperitoneal chemotherapy for gastric cancer | |
| Scientific Title:Acronym | Obeseravational study on safety of intraperitoneal access port system | |
| Region |
|
|
| Condition | ||
| Condition | gastric cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To clarify the safety of intraperitoneal access port system in intraperitoneal chemotherapy for gastric cancer |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | adverse events |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)age ranged between 20 and 75 years old
2)histologically or cytologically proven peritoneal dissemination of gastric cancer 3)peritoneal dissemination with unresectable or recurrent gastric adenocarcinoma 4)performance status (Eastern Cooperative Oncology Group) of 0 to 2 5)an expected survival period of>3 months 6)adequate organ function 7)ability to oral intake 8)written infromed consent |
|||
| Key exclusion criteria | 1)no uncontrolled infection
2)no unsuitable body type for peritoenal accesss prot 3)no allergy for material of peritoneal access port 4)no unsuitalbe skin or subctaneous tissue trouble for peritoneal acesss port. 5)no severe complication 6)no uncontrolled pleural or cardiac effusion 7)no symptomatic brain metastasis 8)no other concurrent malignancies 9)no interstitial pneumoniae or pulmonary fibrosis 10)no pregnant 11)no massive ascites |
|||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kanazawa University | ||||||
| Division name | Gastroenterlogic surgery | ||||||
| Zip code | |||||||
| Address | 13-1 Takaramachi, Kanazawa 920-8641, Japan | ||||||
| TEL | 011-81-76-265-2362 | ||||||
| fushida@staff.kanazawa-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kanazawa University | ||||||
| Division name | Gastroenterlogic surgery | ||||||
| Zip code | |||||||
| Address | 13-1 Takaramachi, Kanazawa 920-8641, Japan | ||||||
| TEL | 011-81-76-265-2362 | ||||||
| Homepage URL | |||||||
| junkino0416@gmail.com | |||||||
| Sponsor | |
| Institute | Kanazawa University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kanazawa university, Gastroenterlogic surgery |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | We observe the frequency of adevere events associated with intraperitoneal acees port system. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000024647 |